English, Coralie, Bayley, Mark, Hill, Kelvin, Langhorne, Peter, Molag, Marja, Ranta, Annemarei, Solomon, John M., Turner, Tari, Campbell, Bruce C. V.. Sage Publications; 2019. Bringing stroke clinical guidelines to life.

Dunphy, Harriette, Garcia-Esperon, Carlos, Collecutt, Wayne, Miteff, Ferdi, Spratt, Neil, Parsons, Mark W., Barber, Peter A., Ranta, Annemarei, Fink, John N., Wu, Teddy Y., Beom Hong, Jae, Manoczki, Csilla, Wilson, Duncan, Chew, Beng Lim Alvin, Beharry, James, Bivard, Andrew, Hasnain, Md Golam, Krauss, Martin. Sage Publications; 2022. Endovascular thrombectomy for acute ischaemic stroke improves and maintains function in the very elderly: A multicentre propensity score matched analysis.

Garcia-Esperon, Carlos, Wu, Teddy Y., Cervera, Alvaro, Wong, Andrew, Mitchell, Peter, Muller, Claire, Rice, Hal, De Villiers, Laetitia, Jannes, Jim, Beom Hong, Jae, Bailey, Peter, Brown, Helen, Carraro do Nascimento, Vincius, Hasnain, Md Golam, Miteff, Ferdinand, Levi, Christopher R., Spratt, Neil J., Bladin, C, Phillips, T, Hasnain, MG, Butcher, K, Miteff, F, Levi, CR, Yan, Bernard, Spratt, NJ, Parsons, MW, ANZ Ultra-Long EVT Transfer Group,, Kurunawai, Craig, Kleinig, Tim, Selkirk, Gregory, Blacker, David, Barber, P. Alan, Ranta, Annemarei. Lippincott Williams & Wilkins; 2023. Ultra-Long Transfers for Endovascular Thrombectomy - Mission Impossible?: The Australia-New Zealand Experience.

Yassi, Nawaf, Zhao, Henry, Jeng, Jiann-Shing, Choi, Philip M. C., Duc, Phuc Dang, Brown, Helen, Ranta, Annemarei, Spratt, Neil, Cloud, Geoffrey C., Wang, Hao-Kuang, Grimley, Rohan, Mahawish, Karim, Churilov, Leonid, Cho, Der-Yang, Shah, D, Nguyen, TMP, Sharma, G, Yogendrakumar, V, Yan, B, Harrison, EL, Devlin, M, Cordato, D, Martinez-Majander, N, Wu, Teddy Y., Strbian, D, Thijs, V, Sanders, LM, Anderson, D, Parsons, MW, Campbell, BCV, Donnan, GA, Davis, SM, Ma, Henry, Nguyen, Huy-Thang, Cheung, Andrew, Meretoja, Atte, Mai, Duy Ton, Kleinig, Timothy. The Lancet Publishing Group; 2024. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial.